Patent Yard Sign in
European application, no grantEurope

5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione,maleic acid salt,hydrate as pharmaceutical

EP 1661895 A1 · Applicant: SMITHKLINE BEECHAM PLC

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed December 14, 1998 and never granted as a European patent. Had it been granted, its 20-year term would have ended December 14, 2018.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by June 14, 2024.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledDecember 14, 1998
PublishedMay 31, 2006
GrantedNever granted
Term endedDecember 14, 2018
Application numberEP 05077331
Classification (CPC)A61P3/00 +2 more

Timeline

Timeline From EPO dates

1999200120032005200720092011201320152017Application filedDec 14, 1998PublishedMay 31, 2006Term endedDec 14, 2018

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.